Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers Journal Article

   

Authors:	Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; Riely, G. J.; Rudin, C. M.; Kris, M. G.; Travis, W.; Drilon, A.; Arcila, M. E.; Ladanyi, M.; Yu, H. A.
Article Title:	Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
Journal Title:	JCO Precision Oncology
Volume:	2
ISSN:	2473-4284
Publisher:	American Society of Clinical Oncology
Date Published:	2018-01-01
Language:	English
DOI:	10.1200/po.18.00126
PROVIDER:	scopus
PMCID:	PMC6447364
PUBMED:	30957057
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077486491&doi=10.1200%2fPO.18.00126&partnerID=40&md5=d3c6fb00c7d30403477c8c555644131b
Notes:	Article -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/159751